Multiple myelomaHSU, Danny C; WILKENFELD, Peter; JOSHUA, Douglas E et al.BMJ (Overseas and retired doctors ed.). 2012, Vol 344, Num 7840, pp 47-49, issn 1759-2151, 3 p.Article

Monoclonal gammopathy of undetermined significance: a consensus statementBERENSON, James R; ANDERSON, Kenneth C; LONIAL, Sagar et al.British journal of haematology. 2010, Vol 150, Num 1, pp 28-38, issn 0007-1048, 11 p.Article

A randomized trial of high- versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabineBRADSTOCK, Kenneth F; MATTHEWS, Jane P; SCHWARER, Anthony P et al.Blood. 2005, Vol 105, Num 2, pp 481-488, issn 0006-4971, 8 p.Article

Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival : an analysis of 10 549 patients from the International Myeloma Working GroupLUDWIG, Heinz; DURIE, Brian G. M; WESTIN, Jan et al.Blood. 2008, Vol 111, Num 8, pp 4039-4047, issn 0006-4971, 9 p.Article

Missense C168T in the Wiskott-Aldrich Syndrome protein gene is a common mutation in X-linked thrombocytopeniaLYE LIN HO; AYLING, Juliet; PROSSER, Ian et al.British journal of haematology. 2001, Vol 112, Num 1, pp 76-80, issn 0007-1048Article

CD86⁺ or HLA-G⁺ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosisBROWN, Ross; KABANI, Karieshma; HART, Derek et al.Blood. 2012, Vol 120, Num 10, pp 2055-2063, issn 0006-4971, 9 p.Article

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3DIMOPOULOS, Meletios; KYLE, Robert; AVET-LOISEAU, Hervé et al.Blood. 2011, Vol 117, Num 18, pp 4701-4705, issn 0006-4971, 5 p.Article

Future Directions of Next-Generation Novel Therapies, Combination Approaches, and the Development of Personalized Medicine in MyelomaMITSIADES, Constantine S; DAVIES, Faith E; LAUBACH, Jacob P et al.Journal of clinical oncology. 2011, Vol 29, Num 14, pp 1916-1923, issn 0732-183X, 8 p.Article

Individualizing Treatment of Patients With Myeloma in the Era of Novel AgentsSAN-MIGUEL, Jesus; HAROUSSEAU, Jean-Luc; JOSHUA, Douglas et al.Journal of clinical oncology. 2008, Vol 26, Num 16, pp 2761-2766, issn 0732-183X, 6 p.Article

The impact of mandatory fortification of flour with folic acid on the blood folate levels of an Australian populationBROWN, Ross D; LANGSHAW, Mark R; UHR, Elaine J et al.Medical journal of Australia. 2011, Vol 194, Num 2, pp 65-67, issn 0025-729X, 3 p.Article

Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases : Natural evolution or latrogenic causation?LING, Silvia; JOSHUA, Douglas E; GIBSON, John et al.American journal of hematology. 2006, Vol 81, Num 2, pp 110-114, issn 0361-8609, 5 p.Article

Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survivalHO, P. Joy; BROWN, Ross D; PELKA, Gregory J et al.Blood. 2001, Vol 97, Num 2, pp 490-495, issn 0006-4971Article

Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8⁺CD57⁺CD28^- compartmentSZE, Daniel M.-Y; GIESAJTIS, Gillian; BROWN, Ross D et al.Blood. 2001, Vol 98, Num 9, pp 2817-2827, issn 0006-4971Article

Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1LING, Silvia C. W; LAU, Edwin K. K; JOSHUA, Douglas E et al.Haematologica (Roma). 2012, Vol 97, Num 1, pp 64-72, issn 0390-6078, 9 p.Article

Clonal expansions of cytotoxic T cells exist in the blood of patients with Waldenström macroglobulinemia but exhibit anergic properties and are eliminated by nucleoside analogue therapyJIA LI; SZE, Daniel M.-Y; YAMAGISHI, Tetsuo et al.Blood. 2010, Vol 115, Num 17, pp 3580-3588, issn 0006-4971, 9 p.Article

Response assessment in Waldenström macroglobulinaemia: update from the Vlth International WorkshopOWEN, Roger G; KYLE, Robert A; ANDERSON, Kenneth C et al.British journal of haematology. 2013, Vol 160, Num 2, pp 171-176, issn 0007-1048, 6 p.Article